open access

Journal of Nanoscience and Nanomaterials

ISSN: 3108-2084 (Online)
DOI Prefix (Crossref): 10.67238

Editor-in-Chief

Editor in Chief Image

Andrey Nikolaevych Belousov (Doctor of Medicine) [View Profile] [ Institutional Profile Link ]

Editor-in-Chief

Department: Department of Applied Nanotechnology

Affiliation: Applied Nanotechnology, Kharkiv National Medical University, Kharkiv

Designation: Professor

Email:

Country: Ukraine

Biography

Professor Andrey Nikolaevych Belousov graduated from Kharkiv Medical Institute in 1988. He has held a Doctor of Medicine degree in Anesthesiology and Intensive Care since 2004. He is the author of the world’s first clinically approved and officially registered nanotechnology-based drugs (1995) used in medical practice.The title dissertation:“Extracorporal hemocorrection using magnet-controlled sorbent in intensive therapy of intoxication syndromes in patients with hepatopancreatoduodenales diseases” (2004). Author a new medicine products – nanotechnology preparations based on magnetite nanoparticles (Fe3O4 ) of the size 6-12 nm: the peroral form - Micromage-B (the biologically active additive officially registration in Ukraine); Magnet-controlled sorbent brand of MCS-B for extracorporal detoxication of biological liquids (officially registration in Ukraine and was allowed for medical practice); NanoBiocorrector for intravenous application – ICNB (intracorporal nanosorbent). Andrey Belousov is author new method of extracorporal hemocorrection using magnet-controlled sorbent (MCS-B). Author a new program (PHUAS) for estimation degree the severity of the patient. The published more 340 scientific works. He has got 8 patents for the invention. Author of the scientific film which focuses on the elaboration of artificial liver device and the development of a new direction in medicine – Nanotechnology. Andrey Belousov was awarded Medical Diploma of Europe “An Honorary Scholar Europe” and R. Koch medal for the scientific achievements, development of a new direction in medicine and elaboration of new method of treatment by means preparations of nanotechnology in 2008. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies, DM, Professor of Department Anaesthesiology, Intensive Care and Paediatric Anaesthesiology of Kharkiv National Medical University, Ukraine. His research interests include nanomedicine, detoxification technologies, critical care pharmacology, and blood rheology correction. He continues to lead multidisciplinary research on the clinical application of nanostructured materials in medicine, contributing to the advancement of personalized and non-invasive therapies.

×

Contact Emails

nanoscience@confmeets.net
support@confmeets.com
finance@confmeets.com
editorial@confmeets.com

ARTICLE PROCESSING TIMELINE

Stage 1 Initial Quality & Plagiarism Check
The manuscript is reviewed for journal scope, basic submission requirements, ethical compliance, and similarity/plagiarism concerns.
Stage 2 Editorial Assessment & Peer Review
Manuscripts that pass the initial screening undergo editorial assessment and independent peer review in accordance with the journal's peer-review policy.
Stage 3 Revision & Editorial Decision
Authors may be requested to revise their manuscript based on reviewer and editor comments. A final editorial decision is made after the required review and revision stages are completed.
Stage 4 Production & Publication
Accepted manuscripts proceed to production, author proofing, final quality checks, and online publication.
Processing Time Notice: Processing times vary depending on the nature and complexity of the manuscript, reviewer availability, the extent of revisions required, author response times, and production requirements. The journal does not guarantee a fixed peer-review or publication timeframe.

EDITORIAL & PUBLICATION INFORMATION

English Publication Language
Single-Blind Peer-Review Model
17% Acceptance Rate
<18% Similarity Screening Guideline
Open Access Access Model

All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.

WHY PUBLISH WITH US?

  • Rigorous Peer Review
  • Rapid Publication
  • Global Open Access
  • Crossref DOI
  • International Editorial Board
  • Global Visibility
  • Plagiarism Screening
  • Dedicated Author Support
  • Special Issues
  • Transparent Publication Process
  • High Publishing Standards
  • Worldwide Research Community
  • JOURNAL FLYER

    Flyer Image